Picture of Akoya Biosciences logo

AKYA — Akoya Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Akoya Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary

* Akoya Biosciences Inc  AKYA.OQ  reported a quarterly
adjusted
loss of 21 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -26 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 20 cents per
share. Wall Street expected results to range from -26 cents
to -16 cents per share.
    * Revenue fell 25.1% to $18.81 million from a year ago;
analysts
expected $25.42 million. 
    * Akoya Biosciences Inc's reported EPS for the quarter was a
loss
of 21 cents​.
    * The company reported a quarterly loss of $10.53 million.
    * Akoya Biosciences Inc shares had risen by 15.1% this
quarter and
lost 35.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Akoya Biosciences
Inc is 4.00 
This summary was machine generated from LSEG data November 15 at
02:09 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.20          -0.21          Missed
 Jun. 30 2024      -0.29          -0.27          Beat
 Mar. 31 2024      -0.29          -0.48          Missed
 Dec. 31 2023      -0.27          -0.22          Beat

Recent news on Akoya Biosciences

See all news